47045-NPL-Z-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Nepal, Multicomponent, United Nations Development Programme Goals: Accelerate Nepal's HIV response to achieve zero new infections, zero AIDS-related deaths, and eliminate HIV inequalities by 2030, as per NHSP 2021-2026; Nepal has set a goal to decrease incidence rate from 238 in 2020/21 to 181 per 100,000 population by 2025/26; decrease mortality rate from 58 in 2020/21 to 23 per 100,000 by 2025/26; end TB epidemic by 2035; eliminate TB by 2050; and reduce the catastrophic cost to zero; Reduce the indigenous malaria cases to zero by 2026 and sustain thereafter; Sustain zero malaria mortality. Objectives: Increase access to people-centered services across the HIV prevention and care continuum; Optimize health outcomes for people living with HIV and key populations; Strengthen community and health system resilience to reduce barriers to HIV prevention, treatment and care; To build and strengthen political commitment, sustainability and patient-friendly health system to end TB; To ensure the identification of TB, diagnosis, quality treatment and prevention; To ensure proportional and equitable access to quality assured diagnosis and treatment in health facilities as per federal structure and implement effective preventive measures to achieve malaria elimination. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Manab Basnet Fund Portfolio Manager +41 58 791 1700 manab.basnet@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nepal HIV Tuberculosis Multicomponent, RSSH Malaria Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Differentiated HIV Testing Services -> Self-testing outside of KP and AGYW programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis HIV -> Prevention package for other vulnerable populations (OVP) -> Community empowerment for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Condom and lubricant programming for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Removing human rights-related barriers to prevention for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Community empowerment for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Condom and lubricant programming for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> HIV prevention communication, information and demand creation for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Removing human rights-related barriers to prevention for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring rights-based law enforcement practices HIV -> Reducing human rights-related barriers to HIV/TB services -> Improving laws, regulations and policies relating to HIV and HIV/TB HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Malaria -> Case management -> Epidemic preparedness Malaria -> Case management -> Facility-based treatment Malaria -> Case management -> Integrated community case management (iCCM) Malaria -> Case management -> Intensified activities for elimination Malaria -> Case management -> Private sector case management Malaria -> Case management -> Therapeutic efficacy surveillance Malaria -> Vector control -> Entomological monitoring Malaria -> Vector control -> Indoor residual spraying (IRS) Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: ANC Malaria -> Vector control -> Insecticide treated nets (ITNs) - Mass campaign: universal Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Community health workers: In-service training RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Integrated supportive supervision for health workers (excluding CHWs) RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Biosafety and biosecurity, infrastructure and equipment RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory Information systems RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory supply chain systems RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory-based surveillance RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: National laboratory governance and management structures RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Specimen referral and transport system RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination RSSH -> RSSH: Community systems strengthening -> Community-led monitoring RSSH -> RSSH: Health products management systems -> Planning and procurement capacity RSSH -> RSSH: Health products management systems -> Storage and distribution capacity, design & operations RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Urban poor/slum dwellers Tuberculosis -> Removing human rights and gender related barriers to TB services -> Community mobilization and advocacy, including support to TB survivor-led groups Tuberculosis -> Removing human rights and gender related barriers to TB services -> Eliminating TB-related stigma and discrimination Tuberculosis -> Removing human rights and gender related barriers to TB services -> Reducing TB-related gender discrimination, harmful gender norms and violence Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC) Tuberculosis -> TB/DR-TB Prevention -> Screening/testing for TB infection Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 26771662.81 14749594.22 18079105.00 Global Fund commitment to NPL-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 12688844.00 Global Fund disbursement to NPL-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5390261.00 Global Fund disbursement to NPL-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2662518.00 Global Fund commitment to NPL-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2662518.00 Global Fund disbursement to NPL-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 13031995.00 Global Fund commitment to NPL-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5099684.00 Global Fund disbursement to NPL-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4142562.00 Global Fund disbursement to NPL-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3789749.00 Global Fund disbursement to NPL-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3814299.31 Expenditure reported by United Nations Development Programme for NPL-Z-UNDPP01, Feb 2025 to Jul 2025. United Nations Development Programme An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR1427-NPL-M. Funding Request of funding request FR1426-NPL-T. Funding Request of funding request FR1425-NPL-H. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. (3) The Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data. Prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any law or regulation applicable to the Principal Recipient. 2 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 11,926,151 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 4.2(a) and 4.2(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in the co-financing commitment letter to be signed by the Government of Nepal and submitted in form and substance satisfactory to the Global Fund, by 30 April 2025: (a) fulfil a total minimum co-financing commitment; (b) fulfil the programmatic commitments (if any) as stipulated in the co-financing commitment letter; and (c) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV, Tuberculosis and Malaria for the upcoming year; and ii. the total expenditure for HIV, Tuberculosis and Malaria in the previous fiscal year. 3 - To the extent consistent with and without prejudice to the Framework Agreement and, in particular, Article 2 of the UNDP-Global Fund Grant Regulations, the Principal Recipient shall be guided by the Global Fund Guidelines for Grant Budgeting (2023, as amended from time to time, available at the Global Fund’s Internet site) in the budgeting of the Grant. 4 - For the purposes of this Grant Agreement, Article 27 of the UNDP-Global Fund Grant Regulations as set out in Annex A of the Framework Agreement shall be deleted in its entirety and replaced with the following: Article 27. CONFLICTS OF INTEREST; PROHIBITED PRACTICES; PROTECTION OF CHILDREN’S RIGHTS a. For each Program, the Global Fund and the Principal Recipient agree that it is important to take all necessary precautions to avoid conflicts of interest and prohibited practices and to protect children’s rights (as described in this Article). To this end, and without prejudice to the terms of Articles 29 or 30 of the UNDP-Global Fund Grant Regulations, the Principal Recipient shall: i. maintain and enforce standards of conduct and fiduciary management that govern the performance of its staff, including without limitation, the prohibition of conflicts of interest and prohibited practices and the protection of children’s rights, in connection with the award and administration of contracts, grants, or other benefits, consistent with the relevant policies of the Principal Recipient, including the Principal Recipient’s policy provisions on conflicts of interest, the "Staff Regulations and Rules of the United Nations", “UNDP Policy against Fraud and other Corrupt Practices”, the Principal Recipient’s “Anti-Money Laundering and Countering the Financing of Terrorism Policy”, the relevant financial regulations and rules applicable to the Principal Recipient, the Principal Recipient's procurement policies and procedures, the United Nations Convention on the Protection of the Rights of the Child and the relevant UNDP Social and Environmental Standards; ii. and cause Sub-recipients and suppliers to maintain and enforce standards of conduct and fiduciary management, including without limitation, the prohibition of conflicts of interest and prohibited practices and the protection of children’s rights, consistent with the substantive requirements contained in the relevant policies of the Principal Recipient, including the Principal Recipient’s policy provisions on conflicts of interest, the relevant provisions in the Principal Recipient’s Financial Regulations and Rules, the United Nations Convention on the Protection of the Rights of the Child, the relevant UNDP Social and Environmental Standards, “UNDP Policy against Fraud and other Corrupt Practices”, the Principal Recipient’s “Anti-Money Laundering and Countering the Financing of Terrorism Policy” and other relevant Principal Recipient policies and procedures. The standards referenced in sub-paragraphs a. i) and ii) above, which the Principal Recipient represents in sub-paragraph g. i) below are materially consistent in substance and scope with the “Article 27 Global Fund policies and procedures” (as such term is defined in sub-paragraph g. i) below), shall govern the performance of the Principal Recipient and any Sub-recipient or supplier (including their staff, individual contractors, counterpart government officials), in connection with Global Fund-financed programs and the award and administration of contracts, grants, or other benefits relating thereto. b. No person affiliated with the Principal Recipient, Sub-recipient or supplier (including their staff, individual contractors, counterpart government officials) shall participate in the selection, award or administration of a contract, grant or other benefit or transaction funded by the Grant, in which the person, members of the person's immediate family or his or her business partners, or organizations controlled by or substantially involving such person, has or have a financial interest. No person affiliated with the Principal Recipient, Sub-recipient or supplier (including their staff, individual contractors, counterpart government officials) shall participate in such transactions involving organizations or entities with which or whom that person is negotiating or has any arrangement concerning prospective employment. Persons affiliated with the Principal Recipient, Sub-recipient or supplier (including their staff, individual contractors, counterpart government officials) shall not solicit gratuities, favors or gifts from contractors or potential contractors. c. If the Principal Recipient has knowledge or becomes aware of any actual, apparent or potential (i) non-compliance with any of the standards referred to in this Article 27; and/or (ii) conflict between the financial interests of any person affiliated with the Principal Recipient, Sub-recipient or supplier, the CCM or, as the case may be, the RCM or RO, the LFA, or the Global Fund and that person’s duties with respect to the implementation of the Program, the Principal Recipient shall immediately disclose such knowledge and awareness directly to the Global Fund. The Principal Recipient shall cause Sub-recipients and suppliers to maintain and enforce similar disclosure obligations to the Principal Recipient for onward reporting to the Global Fund. The disclosure obligations in this sub-paragraph c. are subject to, and without prejudice of, the provisions of sub-paragraphs d. and e. below. d. As applicable pursuant to the working arrangements between the independent oversight offices of the Principal Recipient and the Global Fund and consistent with its rules, policies and procedures and integrity of the investigative process, the Principal Recipient shall keep the Global Fund informed of the progress, findings and outcomes of any investigation concerning the improper use of Global Fund resources, and the OAI shall cooperate and share information with the Global Fund to the fullest extent possible, including where possible, sharing a copy of the final report with the OIG. e. For the avoidance of any doubt, and without prejudice to the terms of Articles 4.1 to 4.3 (inclusive) of the Framework Agreement and Article 16 of the UNDP-Global Fund Grant Regulations, the Global Fund reserves the right to make a determination regarding the use of Grant Funds consistent with the standards contained in the “Article 27 Global Fund policies and procedures”, as such term is defined at sub-paragraph g. i) below. f. The Global Fund and the Principal Recipient shall neither offer a third person nor seek, accept or be promised directly or indirectly for themselves or for another person or entity any gift or benefit that would or could be construed as an illegal or corrupt practice. The Principal Recipient shall cause Sub-recipients and suppliers to maintain and enforce the same obligations. g. The Principal Recipient acknowledges that the Global Fund relies upon the following representations of the Principal Recipient to ensure that all necessary precautions are taken to avoid conflicts of interest and prohibited practices and to protect children’s rights: i. The Principal Recipient represents that as at [insert date GC is sent to UNDP for signature], there is no potential or actual inconsistency between, and/or material difference in the substance or scope of the UNDP policies and procedures mentioned or described in sub-paragraphs a. i) and ii) above and the Global Fund’s Code of Conduct for Recipients of Global Fund Resources, Code of Conduct for Suppliers, as well as with the ban on “Prohibited Practices” as defined in the Global Fund Policy to Combat Fraud and Corruption (together, the “Article 27 Global Fund policies and procedures”), including the remedial actions available to the Global Fund with respect to the Principal Recipient, Sub-recipient and/or supplier, as stipulated in this Framework Agreement and the Article 27 Global Fund policies and procedures. Also, for the avoidance of doubt, the UNDP policies mentioned in this Article 27 do not regulate Sexual Exploitation, Abuse and Sexual Harassment, which are instead governed by Article 30 of the UNDP-Global Fund Grant Regulations; and ii. The Principal Recipient shall, on each occurrence and on a continuing basis, promptly notify the Global Fund in writing if the Principal Recipient considers that there may be any potential or actual inconsistency between, and/or material difference in the substance or scope (including the remedial actions available to the Global Fund with respect to the Principal Recipient, Sub-recipient and/or supplier) of the UNDP policies and procedures mentioned or described in sub-paragraphs a. i) and ii) above and the Article 27 Global Fund policies and procedures, as currently in place or as may be amended in the future (each such notification, a “UNDP Notification”). For such purposes, the Global Fund will promptly notify the Principal Recipient of any amendments to the Article 27 Global Fund policies and procedures. Within 30 calendar days after each relevant UNDP Notification, the Parties agree to discuss in good faith any amendments that may be required to this Article as may be mutually agreed by the Parties, in accordance with Article 20 of the UNDP-Global Fund Grant Regulations. If the Parties are unable to agree any such amendments within such time, then either Party may terminate or suspend the Grant Agreement (in whole or in part) in accordance with Article 21 of the UNDP- Global Fund Grant Regulations. 5 - Downstream Indemnity : Without prejudice to Article 28 of the UNDP-Global Fund Grant Regulations and this Grant Agreement, the Principal Recipient shall ensure through the inclusion and enforcement of contractual obligations in all relevant contracts, that its Sub-recipients and suppliers that are not a United Nations entity, shall defend, indemnify and hold harmless the Global Fund, its directors, officers and employees and any of the Global Fund’s agents and contractors from and against: a. any and all losses of the Global Fund, its directors, officers and employees; and b. any and all claims, liabilities, actual or contingent suits, actions (including charges, disbursements and reasonable fees of counsel), proceedings, damages, expenses and obligations of any kind that may be incurred by the Global Fund or asserted against the Global Fund, its directors, officers and employees by or on behalf of any person on account of, based or resulting from, arising out of (or which may be claimed to arise out of) the acts or omissions of the Sub-recipient or supplier, and any of their agents, employees, assignees, transferees, delegees or successors (“Covered Acts or Omissions”). For the avoidance of doubt, Covered Acts or Omissions include the publication or dissemination of any information derived from or related to the implementation of the Program, including without limitation, the Global Fund’s:  (i) determination of compliance with the Grant Agreement (including any downstream obligations contained therein) by  the Principal Recipient, any Sub-recipient or supplier and any of their agents, employees, assignees, transferees, delegees or successors; and/or (ii) management actions taken in relation to the Program, the Principal Recipient, any Sub-recipient or supplier and any of their agents, employees, assignees, transferees, delegees or successors. 2/ Without prejudice to Article 28 of the UNDP-Global Fund Grant Regulations and the Grant Agreement, the Principal Recipient shall ensure that the downstream indemnity described in Section 1 (above) is enforceable by the Global Fund, without limitation, through the assignment of relevant rights to the Global Fund, at its request and if permissible under the governing law of the relevant contract between the Principal Recipient and its Sub-recipient or supplier. Module: Differentiated HIV Testing Services. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Module: Differentiated HIV Testing Services. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 688876; Denominator: 844332. Numerator: 724948; Denominator: 1302107.53. Numerator: 62512; Denominator: 1302108. Numerator: 487596; Denominator: 764857. Numerator: 741550; Denominator: 1302107.53. Numerator: 487596; Denominator: 764857. Numerator: 330017; Denominator: 764857. Numerator: 552609; Denominator: 764857. Numerator: 623330; Denominator: 771926. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2416; Denominator: 2570. Numerator: 1012; Denominator: 1065. Numerator: 1028; Denominator: 1072. Numerator: 1012; Denominator: 1065. Numerator: 1853; Denominator: 1950. Numerator: 841; Denominator: 885. Numerator: 160; Denominator: 70. Numerator: 841; Denominator: 885. Numerator: 652; Denominator: 686. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 662. Numerator: 662. Numerator: 7004. Numerator: 7004. Numerator: 18245. Numerator: 18245. Numerator: 1170; Denominator: 3347; Percentage: 34.96%. Numerator: 1170; Denominator: 3347; Percentage: 34.96%. Numerator: 24741; Denominator: 30125; Percentage: 82.13%. Numerator: 24741; Denominator: 30125; Percentage: 82.13%. Numerator: 25877; Denominator: 34388; Percentage: 75.25%. Numerator: 28502.3; Denominator: 33532; Percentage: 85%. Numerator: 9696; Denominator: 33532; Percentage: 28.92%. Numerator: 184. Numerator: 1809. Numerator: 7703. Numerator: 470. Numerator: 9226. Numerator: 28502; Denominator: 44759.9; Percentage: 63.68%. Numerator: 58960; Denominator: 89933.5; Percentage: 65.6%. Numerator: 30458; Denominator: 45173.59; Percentage: 67.42%. Numerator: 3124; Denominator: 414; Percentage: 754.59%. Numerator: 290. Numerator: 3163. Numerator: 17577. Numerator: 1012. Numerator: 20018. Numerator: 30458; Denominator: 45173.59; Percentage: 67.42%. Numerator: 32447; Denominator: 45591.11; Percentage: 71.17%. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 2; Denominator: 2. Numerator: 3; Denominator: 9. Numerator: 0; Denominator: 9. Numerator: 12; Denominator: 21. Numerator: 12; Denominator: 21. Numerator: 14; Denominator: 14. Numerator: 21; Denominator: 21. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 147; Denominator: 693. Numerator: 68; Denominator: 456. Numerator: 81; Denominator: 269. Numerator: 120; Denominator: 1202. Numerator: 60; Denominator: 601. Numerator: 60; Denominator: 601. Numerator: -54; Denominator: 29. Numerator: 43; Denominator: 860. Numerator: 43; Denominator: 860. Module: Key and vulnerable populations (KVP) - TB/DR-TB. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Module: Prevention package for other vulnerable populations (OVP). Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 36285.06. Numerator: 36285.06. Numerator: 51835.8. Numerator: 51835.8. Numerator: 430237.14. Numerator: 430237.14. Numerator: 850195; Denominator: 844332; Percentage: 100.69%. Numerator: 852880; Denominator: 1302107.53; Percentage: 65.5%. Numerator: 121253; Denominator: 1302108; Percentage: 9.31%. Numerator: 1893. Numerator: 12896. Numerator: 106464. Numerator: 872412; Denominator: 1302107.53; Percentage: 67%. Numerator: 573643; Denominator: 764857; Percentage: 75%. Numerator: 573643; Denominator: 764857; Percentage: 75%. Numerator: 456111; Denominator: 764857; Percentage: 59.63%. Numerator: 5164. Numerator: 36476. Numerator: 414471. Numerator: 650128; Denominator: 764857; Percentage: 85%. Numerator: 733330; Denominator: 771926; Percentage: 95%. Module: Prevention package for people who use drugs (PUD) and their sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Module: Prevention package for people who use drugs (PUD) and their sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 0. Numerator: 0. Numerator: 2037.07. Numerator: 2037.07. Numerator: 27063.93. Numerator: 27063.93. Numerator: 1372; Denominator: 3347; Percentage: 40.99%. Numerator: 1372; Denominator: 3347; Percentage: 40.99%. Numerator: 27729; Denominator: 30125; Percentage: 92.05%. Numerator: 27729; Denominator: 30125; Percentage: 92.05%. Numerator: 29313; Denominator: 34388; Percentage: 85.24%. Numerator: 31500; Denominator: 33532; Percentage: 93.94%. Numerator: 25274; Denominator: 33532; Percentage: 75.37%. Numerator: 528. Numerator: 5320. Numerator: 19426. Numerator: 1368. Numerator: 23906. Numerator: 31690; Denominator: 44759.9; Percentage: 70.8%. Numerator: 31880; Denominator: 45173.6; Percentage: 70.6%. Numerator: 31880; Denominator: 45173.59; Percentage: 70.57%. Numerator: 27584; Denominator: 45174; Percentage: 61.06%. Numerator: 464. Numerator: 4363. Numerator: 22757. Numerator: 1193. Numerator: 26391. Numerator: 32070; Denominator: 45173.59; Percentage: 70.99%. Numerator: 32447; Denominator: 45591.11; Percentage: 71.17%. Module: TB diagnosis, treatment and care. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 12045; Denominator: 19746. Numerator: 6504; Denominator: 18284. Numerator: 27864; Denominator: 42868. Numerator: 13932; Denominator: 21434. Numerator: 13932; Denominator: 21434. Numerator: 4076; Denominator: 2752. Numerator: 16382; Denominator: 23402. Numerator: 16382; Denominator: 23402. Module: TB diagnosis, treatment and care. Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 2725; Denominator: 23061. Numerator: 2820; Denominator: 19746. Numerator: 1475; Denominator: 18284. Numerator: 3405; Denominator: 21434. Numerator: 6810; Denominator: 42868. Numerator: 3405; Denominator: 21434. Numerator: 292; Denominator: 2752. Numerator: 4110; Denominator: 23402. Numerator: 4110; Denominator: 23402. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 5513; Denominator: 22421; Percentage: 24.59%. Numerator: 5513; Denominator: 22421; Percentage: 24.59%. Numerator: 534; Denominator: 1381; Percentage: 38.67%. Numerator: 534; Denominator: 1381; Percentage: 38.67%. Numerator: 6024; Denominator: 25728; Percentage: 23.41%. Numerator: 6484; Denominator: 26374; Percentage: 24.58%. Numerator: 6702; Denominator: 27054; Percentage: 24.77%. Numerator: 0. Numerator: 0. Numerator: 7578; Denominator: 27039; Percentage: 28%. Numerator: 6943; Denominator: 26704.24; Percentage: 26%. Numerator: 7578; Denominator: 27039; Percentage: 28.03%. Numerator: 14940; Denominator: 28346; Percentage: 52.71%. Numerator: 14746. Numerator: 194. Numerator: 8212; Denominator: 27374.63; Percentage: 30%. Numerator: 9586; Denominator: 27381; Percentage: 35.01%.